BP636

Loperamide N-oxide

British Pharmacopoeia (BP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 106900-12-3

Synonym(S): trans-4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-α,α-diphenyl-1-piperidinebutanamide 1-oxide

Select a Size

Pack Size SKU Availability Price
25 MG BP636-25-MG In Stock ₹ 25,482.05

BP636 - 25 MG

₹ 25,482.05

In Stock

Quantity

1

Base Price: ₹ 25,482.05

GST (18%): ₹ 4,586.769

Total Price: ₹ 30,068.819

grade

pharmaceutical primary standard

API family

loperamide

form

powder

quality

British Pharmacopoeia (BP) Reference Standard

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

application(s)

pharmaceuticalpharmaceutical small molecule

format

neat

storage temp.

2-8°C

InChI

1S/C29H33ClN2O3/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32(35)20-17-28(34,18-21-32)23-13-15-26(30)16-14-23/h3-16,34H,17-22H2,1-2H3

Other Options

Image Product Name Manufacturer Price Range
Sigma Aldrich Fine Chemicals Biosciences Loperamide Related Compound F United States Pharmacopeia (USP) Reference Standard | 106900-12-3 | 25MG
-- ₹ 1,57,601.20
Sigma Aldrich Fine Chemicals Biosciences Loperamide oxide monohydrate European Pharmacopoeia (EP) Reference Standard | 106900-12-3 (anhydrous) |
-- ₹ 24,531.07
Loperamide Related Compound F
-- ₹ 1,39,610.03
Loperamide Related Compound F
-- ₹ 61,799.93
Loperamide oxide
-- --
106900-12-3 | Loperamide
-- ₹ 15,397.00 - ₹ 58,384.00

Related Products

Img

Sigma Aldrich

BP635

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

BP743

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

BP698

British Pharmacopoeia (BP) Referenc...

Img

Sigma Aldrich

BP669

British Pharmacopoeia (BP) Referenc...

Description

  • General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
  • Application: Loperamide N-oxide BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Loperamide Oral Suspension
  • Packaging: Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
  • Other Notes: Sales restrictions may apply.

SAFETY INFORMATION

Pictograms

GHS06

Signal Word

Danger

Hazard Statements

H301

Precautionary Statements

P264 - P270 - P301 + P310 - P405 - P501

Hazard Classifications

Acute Tox. 3 Oral

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable